Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SORD | Q00796 | 3/20 | 0.44 |
| ▸ | KMO | O15229 | 10/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.34 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.34 |
| ▸ | PANK3 | Q9H999 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL287227 | 0.81 | KMO (0.58) | KMO | |
| SCHEMBL2773643 | 0.81 | KMO (0.41) | KMOALDH1A1SMARCA2SMARCA4SMN1; SMN2 | |
| SCHEMBL1206986 | 0.79 | MAP4K4 (0.40) | KMOALDH1A1SMN1; SMN2 | |
| SCHEMBL18824676 | 0.79 | ALDH1A1 (0.40) | KMOALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL282078 | 0.79 | L3MBTL1 (0.38) | KMOSMARCA2SMARCA4SMN1; SMN2 | |
| SCHEMBL23795448 | 0.79 | ATR (0.42) | KMOALDH1A1 | |
| SCHEMBL1256533 | 0.77 | ALDH1A1 (0.47) | SORDKMOALDH1A1PDE3BPDE3A | |
| SCHEMBL882969 | 0.77 | SORD (0.45) | SORDKMOALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8170615 | 0.75 | SORD (0.44) | SORDKMOALDH1A1PDE3BPDE3A | |
| SCHEMBL16421042 | 0.75 | SORD (0.44) | SORDKMOALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3112479-B2 | — | — | 2000-11-27 | — | — | JP | claimed |
| EP-0586393-A1 | SUBSTITUTED-2-PHENYL-3-METHOXYPROPENOATES AS FUNGICIDES | ZENECA LIMITED (GB) | 1994-03-16 | — | — | EP | claimed |
| WO-1992018487-A1 | SUBSTITUTED-2-PHENYL-3-METHOXYPROPENOATES AS FUNGICIDES | ZENECA LIMITED (GB) | 1992-10-29 | — | — | WO | claimed |
| US-20110313156-A1 | HETEROCYCLYL CARBONIC ACID AMIDES AS ANTIPROLIFERATIVE AGENTS, PDKL INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-12-22 | — | — | US | disclosed |
| US-5814633-A | MULTISTAGE FORMATION OF OXYIMINO ANILIDES AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-29 | — | — | US | disclosed |
| CN-1171783-A | Iminooxymethylene anilides, process for their preparation and their use | BASF AG (DE) | 1998-01-28 | — | — | CN | disclosed |
| EP-0793655-A1 | IMINOOXYMETHYLENE ANILIDES, PROCESS FOR PREPARING THE SAME AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1997-09-10 | — | — | EP | disclosed |
| WO-1996016044-A1 | IMINOOXYMETHYLENE ANILIDES, PROCESS FOR PREPARING THE SAME AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-05-30 | — | — | WO | disclosed |
| EP-0586393-A1 | SUBSTITUTED-2-PHENYL-3-METHOXYPROPENOATES AS FUNGICIDES | ZENECA LIMITED (GB) | 1994-03-16 | — | — | EP | disclosed |
| WO-1992018487-A1 | SUBSTITUTED-2-PHENYL-3-METHOXYPROPENOATES AS FUNGICIDES | ZENECA LIMITED (GB) | 1992-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313156-A1 | HETEROCYCLYL CARBONIC ACID AMIDES AS ANTIPROLIFERATIVE AGENTS, PDKL INHIBITORS | PDK2, PDK4, CCNH | SORD 1806/4885KMO 3468/4885ALDH1A1 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.